MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Selective subthalamic DBS improved non-motor disorders without affecting weight gain in parkinsonism

    H. Tibar, K A. Charles, F. Naudet, PH. De-Deurwaerdère, A. Benazzouz (Rabat, Morocco)

    Objective: Evaluate the impact of subthalamic nucleus deep brain stimulation (STN-DBS) on weight gain in Parkinsonian rats: The primary objective would be to determine whether…
  • 2024 International Congress

    How Botulinum Toxin Transformed the American Food Industry

    D. Riley (Cleveland Heights, USA)

    Objective: To highlight an episode of botulism that altered American food packaging technology Background: Early progress in understanding the behavior of botulinum toxin was marked…
  • 2024 International Congress

    A Post-mortem Study on Striatal Glia and Blood Brain Barrier Integrity in Aging and PD Asian-Indians.

    H J. Jyothi, A. Mahadevan, U. Muthane, T C. Yasha, P. Alladi (Bengaluru, India)

    Objective: We examined the glial and blood brain barrier (BBB) changes related to normal aging and PD in the Asian-Indian striatum. Background: increases the risk…
  • 2024 International Congress

    Boosting Parkinson’s Disease Diagnosis: How Training Ethiopian Healthcare Workers and Enhancing Community Level Awareness Led to a Surge in Case Identification

    MRS. Yinesu (Addis Ababa, Ethiopia)

    Objective: The study assessed the effectiveness of a capacity development training program in improving the diagnosis of Parkinson's Disease (PD) by healthcare professionals Background: Parkinson's…
  • 2024 International Congress

    Engage, Educate and Empower: Parkinson’s Research Advocates from the Black and African American Community

    R. Mills-Joseph, K. Gamble, T. Best, K. Williams, L. Wilson, D. Coley, B. Coley, M. Fitts, R. Huckabee, A. Huckabee, E. Lewis, L. Seghetti, C. Branson, H. Shah, A. Kumeh, C. Gallagher, C. Evers, E. Stevens (Columbus, USA)

    Objective: To assess engagement in research advocacy among Black and African people with Parkinson’s and their care partners. Background: Black and African American people with…
  • 2024 International Congress

    Alterations in Monoamine Metabolites in Parkinson’s Disease: A Meta-Analysis

    MA. Muneer, V. Suresh, E. Zulfiqar, S. Saaki, I. Jaffery, V. Chowdary, S. Hurjkaliani (Lahore, Pakistan)

    Objective: To analyze the levels of various monoamine metabolites in patients with Parkinson’s Disease as compared to healthy controls. Background: Monoamine metabolites are the breakdown…
  • 2024 International Congress

    Dynamic video-assessment of axial postural abnormalities in parkinsonism: feasibility and pilot analysis

    C. Geroin, C. Artusi, S. Camozzi, G. Imbalzano, S. Aldegheri, L. Lopiano, N. Bombieri, M. Tinazzi (Verona, Italy)

    Objective: To evaluate changes in the degree of axial postural abnormalities (APAs) using the AutoPosturePD software during standing and walking under single/dual-task conditions. Background: We…
  • 2024 International Congress

    Can Heterozygous Autosomal Recessive Mutations Cause Neurological Disease?

    L. Patil, M. Bhatt (Mumbai, India)

    Objective: To highlight the significance of heterozygous PLA2G6 and PRKN gene mutations in causing parkinsonism. Background: We report our observations in two families with multiple…
  • 2024 International Congress

    Novel ASO Targeting IGHMBP2 Cryptic Splice Variant: Efficacy and Safety

    S. Smieszek, B. Przychodzen, C. Tyner, C. Johnson, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)

    Objective: Our objective was to target a specific cryptic splice site variant affecting immunoglobulin mu‐binding protein 2 (IGHMBP2) protein levels with a novel antisense oligonucleotide…
  • 2024 International Congress

    A Rare Case of Parkinson’ s Disease Associated With Heterozygous ATP13A2 Gene Mutation: What If There Are No Atypical Features with a Later Onset?

    Y. Degirmenci (Istanbul, Turkey)

    Objective: Autosomal recessive mutations in ATP13A2 gene is a rare cause of levodopa-responsive parkinsonism with atypical features of supranuclear gaze palsy, spasticity, dystonia, dementia, myoclonus,…
  • « Previous Page
  • 1
  • …
  • 527
  • 528
  • 529
  • 530
  • 531
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley